Silver nanoparticles have quickly established themselves as a multifaceted nanomaterial in the biomedical field, with their properties widely studied over the last decade. However, there are still concerns regarding its long-term toxicity. Recent developments in nanoparticle fabrication and surface manipulation using various biomolecules have enabled the preparation of nontoxic nanosilver. Thus, nanosilver has been safely incorporated into a variety of regenerative templates for the engineering of tissues such as the cornea, skin, and heart. In addition, it has been incorporated into wound-healing treatments, biosensors, and imaging modalities, among others. In this chapter, a selection of promising synthetic routes for the preparation of biomolecule-capped silver nanoparticles will be discussed and presented. The main goal is to present a rationale for choosing a synthetic route for nanosilver that minimizes/avoids toxic side effects for biomaterial development.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Biomolecule Silver Nanoparticle-Based Materials for Biomedical Applications

  • Nicolás Santos,
  • Erik J. Suuronen,
  • Emilio I. Alarcon,
  • Manuel Ahumada

摘要

Silver nanoparticles have quickly established themselves as a multifaceted nanomaterial in the biomedical field, with their properties widely studied over the last decade. However, there are still concerns regarding its long-term toxicity. Recent developments in nanoparticle fabrication and surface manipulation using various biomolecules have enabled the preparation of nontoxic nanosilver. Thus, nanosilver has been safely incorporated into a variety of regenerative templates for the engineering of tissues such as the cornea, skin, and heart. In addition, it has been incorporated into wound-healing treatments, biosensors, and imaging modalities, among others. In this chapter, a selection of promising synthetic routes for the preparation of biomolecule-capped silver nanoparticles will be discussed and presented. The main goal is to present a rationale for choosing a synthetic route for nanosilver that minimizes/avoids toxic side effects for biomaterial development.